Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients

Acta Diabetologica

Volumn 47, Issue 2, 2010, Pages 113-118

  Park, Jong Suk ^a   Cho, Min Ho ^a   Nam, Ji Sun ^a   Ahn, Chul Woo ^a   Cha, Bong Soo ^a   Lee, Eun Jig ^a   Lim, Sung Kil ^a   Kim, Kyung Rae ^a   Lee, Hyun Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

CRP; Leptin; Type 2 diabetes; Visceral adipose tissue

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEPTIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; SULFONYLUREA DERIVATIVE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY RISK; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CAROTID ARTERY; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HISTOLOGY; INTIMA; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; REGRESSION ANALYSIS; TUNICA MEDIA;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTRA-ABDOMINAL FAT; KOREA; LEPTIN; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGRESSION ANALYSIS; TUNICA INTIMA; TUNICA MEDIA;

EID: 77952780340     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0125-4     Document Type: Article

References (41)

1. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
2. Libby P (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365-372
3. Ramakrishna V, Jailkhani R (2008) Oxidative stress in noninsulin- dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 45:41-46
4. Ridker PM, Buring JE, Cook NR et al (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397
5. Kim CS, Song MK, Park JS et al (2007) The clinical and immunogenetic characteristics of adult-onset type 1 diabetes mellitus in Korea. Acta Diabetol 44:45-54
6. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369
7. Jialal I, Devaraj S (2003) Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol 91:200-202
8. Ridker PM, Rifai N, Pfeffer MA et al (1999) Long-term effects of pravastatin on plasma concentration of C-reactive protein: the cholesterol and recurrent events (CARE) investigators. Circulation 100:230-235
9. Matsumoto K, Sera Y, Abe Y et al (2003) Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 169:317-321
10. Krauss RM, Winston M, Fletcher BJ et al (1998) Obesity: impact on cardiovascular disease. Circulation 98:1472-1476
11. Bouchard L, Faucher G, Tchernof A et al (2009) Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals. Acta Diabetol 46:13-21
12. Tessari P, Tiengo A (2008) Metformin treatment of rats with dietinduced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver. Acta Diabetol 45:143-145
13. Flegal KM, Carroll MD, Ogden CL et al (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727
14. Abdul-Ghani MA, Molina-Carrion M et al (2008) Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 45:147-150
15. Yudkin JS, Stehouwer CD, Emeis JJ et al (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue. Arterioscler Thromb Vasc Biol 19:972-978
16. Festa A, D'Agostino R Jr, Tracy RP et al (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131-1137
17. Hak AE, Stehouwer CD, Bots ML et al (1999) Associations of Creactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19:1986-1991
18. Lemieux I, Pascot A, Prud'homme D et al (2001) Elevated Creactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21:961-967
19. Halaas JL, Gajiwala KS, Maffei M et al (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
20. Wallace AM, McMahon AD, Packard CJ et al (2001) Plasma leptin and the risk for cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052-3056
21. Gomez-Ambrosi J, Salvador J, Silva C et al (2005) Leptin therapy does not affect inflammatory markers. J Clin Endocrinol Metab 90:3803
22. Gomez-Ambrosi J, Salvador J, Paramo JA et al (2002) Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35:315-320
23. Shamsuzzaman AS, Winnicki M, Wolk R et al (2004) Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109:2181-2185
24. Kim DM, Nam SY, Ahn CW et al (2003) Correlation between mid-thigh low density muscle and insulin resistance in obese nondiabetic patients in Korea. Diabtes Care 26:1825-1830
25. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502
26. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
27. Saijo Y, Kiyota N, Kawasaki Y et al (2004) Relationship between C reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 6:249-258
28. Iwasaki T, Nakajima A, Yoneda M et al (2006) Repationship between the serum concentrations of C reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocrine Journal 53:345-356
29. Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850
30. Lear SA, Chen MM, Birmingham CL et al (2003) The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 52:1542-1546
31. Lakoski SG, Cushman M, Criqui M et al (2006) Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 152:593-598
32. Khera A, McGuire DK, Murphy SA et al (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46:464-469
33. Saad MF, Damani S, Gingerich RL et al (1997) Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82:579-584
34. Abdullah SM, Khera A, Leonard D et al (2007) Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 195:404-410
35. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763-770
36. Yanagawa T, Taniguchi A, Fukushima M et al (2007) Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 75:2-6
37. Grunfeld C, Zhao C, Fuller J et al (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97:2152-2157
38. Kirchgessner TG, Uysal KT, Wiesbrock SM et al (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782
39. Santos-Alvarez J, Goberna R, Sanchez-Margalet V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6-11
40. Dowidar L, Dejong CHC, Fearon KCH et al (2000) Effects of leptin on isolated human hepatocyte C reactive protein production. Br J Surg 87:643-644
41. Ble A, Windham BG, Bandinelli S et al (2005) Relation of plasma leptin to CRP Protein in older adults. Am J Cardiol 96:991-995